[1] Zhimin G,Noor H,Zhou JB,et al.Advances in diagnosis and treatment of hilar cholangiocarcinoma:a review.Med Sci Monit,2013,19:648-656. [2] 薛源,苏继荣.肝门部胆管癌的诊断与外科治疗.中国现代药物应用,2013,7(1):19-21. [3] Soares KC,Kamel I,Cosgrove DP,et al.Hilar cholangiocarcinoma:diagnosis,treatment options,and management. Hepatobiliary Surg Nutr,2014,3(1):18-34. [4] Valls C,Ruiz S,Martinez L,et al.Radiological diagnosis and staging of hilar cholangiocarcinoma. World J Gastrointest Oncol,2013,5(7):115-126. [5] 谭福勇. 肝门部胆管癌外科手术治疗的进展. 医学综述,2012,6(18):1863-1866. [6] 周宁新,黄志强,张文智,等. 402例肝门部胆管癌临床分型、手术方式与远期疗效的综合分析. 中华外科杂志,2006,44(23):1599-1603. [7] Castellano-Megías VM,Ibarrola-de Andrés C,Colina-Ruizdelgado F. Pathological aspects of so called “hilar cholangiocarcinoma”. World J Gastrointest Oncol,2013,5(7):159-170. [8] Kitagawa Y,Nagino M,Kamiya J,et al.Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg,2001,233(3):385-392. [9] Mantel HTJ,Wiggers JK,Verheij J,et al.Lymph node micrometastases are associated with worse survival in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg Oncol,2015,22:1107-1115. [10] Prognostic factors for progression-free and overall survival in advanced biliary tract cancer. Ann Oncol,2015,46(1):1-7. [11] Bekaii T,Phelps MA,Li X,et al.Multi-institutional phaseⅡ study of selumetinib in patients with metastatic biliary cancer .J Clin Oncol,2011,29(17):2357-2363. [12] Koerkamp G,Wiggers JK,Allen PJ,et al.Recurrence rate and pattern of perihilar cholangiocarcinoma after curative intent resection. J Am Coll Surg,2015,221(6):1041-1049. [13] Guglielm A,Ruzzenente A,Campagnaro T,et al.Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma. HPB,2011,13:240-245. [14] Ruys AT,Ten Kate FJW,Busch OR,et al.Metastatic lymph nodes in hilar cholangiocarcinoma:does size matter. HPB,2011,13:881-886. [15] Mao K,Liu J,Sun J,et al.Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma. J Gastroenterol Hepatol,2016,31(2):417-426. [16] 刘振国,强永乾. 螺旋CT 和MRI 对肝内周围型胆管癌诊断价值分析. 实用肝脏病杂志,2016,19(5):591-594. [17] Koerkamp G,Wiggers JK,Allen PJ,et al.Recurrence rate and pattern of perihilar cholangiocarcinoma after curative intent resection. J Am Coll Surg,2015,221(6):1041-1049. [18] Amitcohen BC,Rahat MM,Rahat MA.Tumor cell macrophage interactions increase angiogenesis through secretion og EMMMPRIN. Front Physiol,2013,12(4),178-183. [19] Bekaii T,Phelps MA,Li X,et al.Multi-institutional phase Ⅱ study of selumetinib in patients with metastatic biliary cancer. J Clin Oncol,2011,29(17):2357-2363. [20] 易为民,彭创,厉鸥,等. 胆管细胞癌细胞CD147表达及其临床意义. 实用肝脏病杂志,2017,20(11):97-100. |